Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb;19(2):8.
doi: 10.1007/s11920-017-0762-1.

The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says

Affiliations
Review

The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says

Klaus W Lange et al. Curr Psychiatry Rep. 2017 Feb.

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common behavioral disorder in children and adolescents and may persist into adulthood. Insufficient nutritional supply of long-chain polyunsaturated fatty acids (LC-PUFAs) and other components including various minerals has been suggested to play a role in the development of ADHD symptoms. This review presents the evidence regarding the role of nutritional PUFA, zinc, iron, and magnesium supplements in the treatment of ADHD with a focus on the critical evaluation of the relevant literature published from 2014 to April 2016. The evaluation of therapeutic nutritional LC-PUFA supplementation in ADHD has shown mixed and inconclusive results and at best marginal beneficial effects. The benefits of PUFAs are much smaller than the effect sizes observed for traditional pharmacological treatments of ADHD. The effectiveness of PUFA supplements in reducing medication dosage has been suggested but needs to be confirmed. Zinc, iron, and magnesium supplementation may reduce ADHD symptoms in children with or at high risk of deficiencies in these minerals. However, convincing evidence in this regard is lacking.

Keywords: ADHD; Iron; Magnesium; Nutritional supplements; Polyunsaturated fatty acids; Zinc.

PubMed Disclaimer

References

    1. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):299-308 - PubMed
    1. Neurotoxicol Teratol. 2000 Sep-Oct;22(5):631-51 - PubMed
    1. Child Psychiatry Hum Dev. 2016 Apr;47(2):259-69 - PubMed
    1. Lancet. 2005 Jul 16-22;366(9481):237-48 - PubMed
    1. J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):991-1000 - PubMed

MeSH terms

LinkOut - more resources